Stockreport

Sangamo Announces Closing of Biogen Collaboration Agreement

Sangamo Therapeutics, Inc.  (SGMO) 
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sangamo.com
PDF - Sangamo has received $225 million in stock proceeds; will receive additional $125 million upfront license fee by May 8, 2020 BRISBANE, Calif.--(BUSINESS WIRE)--Sang [Read more]